பார்மா செயல்பாடுகள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana
IIoT-OXYS Inc : IIOT-OXYS, Inc s Partner, Aingura IIoT, S L , Wins Contract with ArcelorMittal
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
IIOT-OXYS, Inc s Partner, Aingura IIoT, S L , Wins Contract with ArcelorMittal
newjerseytelegraph.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newjerseytelegraph.com Daily Mail and Mail on Sunday newspapers.
Hikma announces US FDA approval of KLOXXADOTM (naloxone hydrochloride) nasal spray 8mg
Important new option for reversing opioid overdoses
News provided by
Share this article
Share this article
LONDON, April 30, 2021 /PRNewswire/ Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, announces the approval of KLOXXADO
TM (naloxone hydrochloride) nasal spray 8mg, by the US Food and Drug Administration (FDA) for the emergency treatment of known or suspected opioid overdose, as manifested by respiratory and/or central nervous system depression, for adult and pediatric patients.
KLOXXADO
TM contains twice as much naloxone per spray as Narcan
® Nasal Spray 4mg in a ready-to-use nasal spray to reverse the effects of opioid overdose, providing an important new treatment option in addressing the opioid epidemic.